IMVT
Immunovant Inc
34.00$
-1.6%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 99.7% | 99.9% | 99.9% | 99.9% | 98.4% | 98.0% | 98.9% | 98.5% | 98.4% | 99.1% | 99.1% | 99.8% | |
| 92.4% | 97.1% | 95.3% | 95.0% | 91.7% | 89.0% | 92.0% | 90.5% | 89.5% | 94.5% | 94.3% | 93.6% | |
| 92.4% | 97.1% | 95.3% | 95.0% | 91.7% | 89.0% | 92.0% | 90.5% | 89.5% | 94.5% | 94.3% | 93.6% | |
| 0.5% | 0.1% | 0.8% | 0.4% | 0.4% | 0.5% | 0.3% | 0.3% | 0.3% | 0.2% | 0.4% | 0.1% | |
| – | 0.0% | – | – | – | – | – | – | – | – | – | – | |
| 13.8% | 4.5% | 7.3% | 7.6% | 12.9% | 16.2% | 8.9% | 8.0% | 10.9% | 6.3% | 10.9% | 13.7% | |
| 13.8% | 4.5% | 7.3% | 7.6% | 12.9% | 16.2% | 8.9% | 8.0% | 10.9% | 6.3% | 10.9% | 13.7% | |
| 0.2% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | 0.0% | – | |
| 2.6% | 0.5% | 1.1% | 1.9% | 4.0% | 4.7% | 2.3% | 1.2% | 1.2% | 0.8% | 0.8% | 1.2% | |
| 86.2% | 95.5% | 92.7% | 92.4% | 87.1% | 83.8% | 91.1% | 92.0% | 89.1% | 93.7% | 89.1% | 86.3% | |
| -239.3% | -105.5% | -123.8% | -154.8% | -198.2% | -269.2% | -159.7% | -205.6% | -255.0% | -151.8% | -182.4% | -222.7% | |
| 44.9% | 20.3% | 21.8% | 24.8% | 28.4% | 34.9% | 19.5% | 25.8% | 29.8% | 17.2% | 21.3% | 24.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.